CORRADO, ADDOLORATA
 Distribuzione geografica
Continente #
NA - Nord America 8.309
EU - Europa 5.943
AS - Asia 4.420
SA - Sud America 748
AF - Africa 84
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 19.526
Nazione #
US - Stati Uniti d'America 8.191
CN - Cina 1.628
IE - Irlanda 1.578
SG - Singapore 1.549
RU - Federazione Russa 1.019
UA - Ucraina 1.007
SE - Svezia 746
BR - Brasile 610
HK - Hong Kong 455
FR - Francia 397
VN - Vietnam 293
DE - Germania 292
IT - Italia 275
FI - Finlandia 182
GB - Regno Unito 137
IN - India 119
TR - Turchia 118
CZ - Repubblica Ceca 98
CA - Canada 60
AR - Argentina 53
IQ - Iraq 43
BD - Bangladesh 42
PL - Polonia 38
MX - Messico 36
AT - Austria 34
BE - Belgio 30
EC - Ecuador 26
NL - Olanda 25
ZA - Sudafrica 21
JP - Giappone 20
ID - Indonesia 19
UZ - Uzbekistan 18
VE - Venezuela 14
ES - Italia 13
EG - Egitto 12
LT - Lituania 12
PK - Pakistan 12
JO - Giordania 11
PY - Paraguay 11
CL - Cile 10
IR - Iran 10
SA - Arabia Saudita 10
MA - Marocco 9
PE - Perù 9
CO - Colombia 8
DK - Danimarca 8
EU - Europa 8
RO - Romania 8
TN - Tunisia 8
AZ - Azerbaigian 7
PH - Filippine 7
SN - Senegal 7
CH - Svizzera 6
KE - Kenya 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
AU - Australia 5
CI - Costa d'Avorio 5
JM - Giamaica 5
LB - Libano 5
UY - Uruguay 5
DZ - Algeria 4
HR - Croazia 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
NP - Nepal 4
OM - Oman 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CR - Costa Rica 3
GE - Georgia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MN - Mongolia 3
MY - Malesia 3
PA - Panama 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BY - Bielorussia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
KR - Corea 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 19.507
Città #
Dallas 1.821
Dublin 1.575
San Jose 1.098
Singapore 766
Chandler 713
Jacksonville 658
Nyköping 500
Dearborn 455
Hong Kong 448
Ashburn 432
Beijing 384
Nanjing 300
Santa Clara 220
Lauterbourg 188
Princeton 163
Wilmington 157
Munich 132
The Dalles 124
Moscow 118
Los Angeles 112
Ho Chi Minh City 105
Nanchang 95
New York 93
San Mateo 90
Helsinki 87
Brno 79
Ann Arbor 77
Boardman 77
Shenyang 73
Hanoi 61
São Paulo 56
Des Moines 53
Tianjin 49
Hebei 46
Jiaxing 41
Shanghai 41
Guangzhou 39
Kunming 39
Foggia 37
London 36
Woodbridge 36
Changsha 35
Orem 31
Chicago 30
Columbus 30
Frankfurt am Main 30
Nuremberg 27
Zhengzhou 27
Brussels 24
Hangzhou 23
Hillsboro 23
Brooklyn 22
Jinan 22
Baghdad 21
Warsaw 21
Assago 20
Xi'an 19
Rio de Janeiro 18
Seattle 18
Milan 17
San Francisco 17
Turku 17
Guayaquil 16
Tokyo 16
Toronto 16
Bari 15
Chennai 15
Da Nang 15
Lanzhou 15
Montreal 15
Norwalk 15
Tashkent 15
Atlanta 14
Boston 14
Falkenstein 14
Amsterdam 13
Haiphong 13
Ningbo 13
Olomouc 13
Vienna 13
Washington 13
Council Bluffs 12
Hefei 12
Johannesburg 12
Rome 12
Taizhou 12
Belo Horizonte 11
Hanover 11
Paris 11
Stockholm 11
Brasília 10
Buffalo 10
Curitiba 10
Noci 10
Phoenix 10
Pune 10
Salvador 10
San Severo 10
Amman 9
Manchester 9
Totale 12.641
Nome #
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 525
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 474
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 214
A case of rhupus treated with filgotinib: A promising therapeutic perspective 191
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 182
SUBSTANCE P AND VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS DERIVING FROM PATIENTS WITH SYSTEMIC SCLEROSIS 155
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 153
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 151
Extra-skeletal effects of bisphosphonates. 147
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 144
Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. 144
Adult Scheuermann's disease as cause of mechanic dorsalgia 142
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 141
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 139
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 138
Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis 137
Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis 137
Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. 133
Pubic symphysis sclerosis in psoriatic arthritis. Case report. 133
Corticosteroids, a review. 127
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 126
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 125
Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept. 125
Anti-TNF-α and risk of infections: the experience in one center. 124
COUNSELLING ON FAMILY PLANNING AND CONTRACEPTION, AND PREGNANCY OUTCOME IN WOMEN WITH RHEUMATIC DISEASES: A NATIONAL SURVEY OF 398 PATIENT-REPORTED QUESTIONNAIRES FROM 24 RHEUMATOLOGY CENTERS 124
Extracellular Matrix modulates angiogenesis in physiological and pathological conditions 123
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 123
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. 123
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 122
Bisphosphonates: effects on osteoblast. 122
Role of altered osteoblastic expression of Dkk-1 in the pathogenesis of osteoarthritis and osteoporosis 121
TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. 121
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 120
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease. 120
Bone effects of biologic drugs in rheumatoid arthritis. 119
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects 119
Anomalies de la capillaroscopie périunguéale au cours de la fibrose pulmonaire associée à la sclérodermie systémique et au cours de la fibrose pulmonaire idiopathique 119
Obesity and Chronic Inflammation: Implications for Rheumatoid Arthritis, Spondyloarthritis, and Ulcerative Colitis 118
Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis 116
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 115
Mitochondrial disease mimicking polymyositis: a case report 115
Comments on Addolorata Corrado et al. review “Extra-skeletal effects of bisphosphonates” 115
Metabolic effects of zoledronate on primary human osteoblastic cell cultures 114
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment 114
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 114
La coxalgia 113
IgA nephropathy in systemic lupus erythematosus. 112
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches 112
Anabolic therapy of induced osteoporosisin beta-thalassaemia major: case report and literature review 112
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 112
Bisphosphonates and osteoarthritis 111
Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report 110
Systemic effects of Wnt signaling 110
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases 110
Osteocytes: central conductors of bone biology in normal and pathological conditions 109
Osteocalcin: Skeletal and extra-skeletal effects 109
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 109
Integrine expression on human osteoblasts in osteoarthritis 108
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 108
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 108
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 108
SERUM 25(OH) VITAMIN D LEVELS, BODY MASS COMPOSITION AND EXTENT OF SKIN SCLEROSIS IN SYSTEMIC SCLEROSIS PATIENTS 108
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement 108
Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis. 107
THU0145 Changes in bone metabolism and trabecular bone score in patients with early rheumatoid arthritis 107
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 107
Osteoblast physiology in normal and pathological conditions 106
Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis 106
Osteoblast as a target of anti-osteoporotic treatment 106
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database 106
Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. 105
Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms 105
INHIBITORY EFFECT OF 1,25OH VITAMIN D ON IL-17 RELATED PRO-FIBROTIC CYTOKINES EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 105
Effects of Infliximab on human osteoblastic cells from rheumatoid arthrtis subjects 104
Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis 104
Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts 103
AN EXEMPLAR BEHCET CASE, IN ALL ITS MULTISYSTEMIC FEATURES 103
FRI0468 EFFECTS OF DIFFERENT VITAMIN D SUPPLEMENTATION SCHEMES IN POSTMENOPAUSAL WOMEN 103
Impact of Systematic Isolation of Superior Vena Cava in Addition to Pulmonary Vein Antrum Isolation on the Outcome of Paroxysmal, Persistent, and Permanent Atrial Fibrillation Ablation: Results from a Randomized Study 102
EFFECTS OF DIFFERENT ANTI TNF ALPHA TREATMENTS ON LIPID AND CARBOHYDRATE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS 102
Reply to the letter by Baldeep Singh on the review entitled "Extra skeletal effects of bisphosphonates" 102
Successful treatment of avascular bone necrosis of the knee with neridronate: a case report 101
T cells support osteoclastogenesis in an in vitro model derived from human psoriatic arthritis 101
ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN INTRIGUING ASSOCIATION WITH SKIN INVOLVEMENT 101
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study 101
Pathogenesis, clinical findings and management of acute and chronic gout. 101
Osteoporosis and rheumatic diseases 100
Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis 100
Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis 100
Glucocorticoid induced risk of fractures 100
Effects of Infliximab on human osteoblastic cells from rheumatoid arthritis subjects 100
Anti-angiogenic effects of anti–tumor necrosis factor α agents in the treatment of behçet disease 100
AB1099 Counselling on family planning and contraception, and pregnancy outcome in women with rheumatic diseases: a national survey of 398 patient-reported questionnaires from 24 rheumatology centers 100
Cervical myelopathy caused by periodontoid synovial pannus in a patient with psoriatic arthritis: a case report. 99
Neridronate and osteoporotic and ostearthitic human osteoblasts 99
Bilateral sequential central retinal vein occlusion associated with primary antiphospholipid syndrome 98
Membranous nephropathy in rheumatoid arthritis: a case report. 97
Glucocorticoid induced risk of fractures. 97
Combined effects of infliximab and methotrexate on rheumatoid arthritis osteoblastic cell metabolism 97
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 96
Totale 12.452
Categoria #
all - tutte 105.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 0 0 0 0 0 160 3 13
2021/2022840 99 13 9 9 65 18 28 72 134 125 34 234
2022/20233.674 325 162 171 154 189 326 20 306 1.791 30 95 105
2023/2024739 108 39 45 30 44 140 15 28 1 38 19 232
2024/20253.011 167 24 67 113 109 496 280 206 738 215 296 300
2025/20267.240 378 813 1.996 740 301 313 1.268 679 481 271 0 0
Totale 20.241